Medical Xpress·5 min read·hard
Blood marker for protein misfolding outperforms P-tau 217 as early predictor of Alzheimer's disease
R
Ruhr University Bochum
✦AI Summary
A study published in EMBO Molecular Medicine identifies amyloid beta protein misfolding as a highly effective blood-based predictor for Alzheimer's disease in asymptomatic stages. This marker outperforms the widely used P-tau 217 biomarker in early detection.
edited by Lisa Lock , reviewed by Andrew Zinin
sciencehealth
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in